# FDA recall D-1467-2019

> **American Health Packaging** · Class II · drug recall initiated 2019-05-09.

## Product

Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by:  Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories

## Reason for recall

GMP Deviations: Potential cross contamination due to cleaning procedure failure.

## Distribution

Nationwide USA

## Key facts

- **Recall number:** D-1467-2019
- **Recalling firm:** American Health Packaging
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-05-09
- **Report date:** 2019-07-17
- **Termination date:** 2020-09-09

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Columbus, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1467-2019

## Citation

> AI Analytics. FDA recall D-1467-2019. Retrieved 2026-07-17 from https://api.ai-analytics.org/recall/D-1467-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*